ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Campbell, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campbell, D. B.

Ann Thorac Surg 1997;63:1503-1505
© 1997 The Society of Thoracic Surgeons

Key References

Malignant Mesothelioma

David B. Campbell, MD

Division of Cardiothoracic Surgery, The Milton S. Hershey Medical Center, Pennsylvania State University, Hershey, Pennsylvania

Footnotes

Address reprint requests to Dr Campbell, Hershey Medical Center, PO Box 850, Hershey, PA 17033-0850.

Current Review Articles

  1. Aisner J. Current approach to malignant mesothelioma of the pleura. Chest 1995;107:332S--44S.[Abstract/Free Full Text]
  2. Donington JS, Mew DJ, Pass HI. Malignant pleural mesothelioma: newer aspects of carcinogenesis, molecular genetics, and prospects for future therapies. Surg Oncol 1995;4:175–85.[Medline]
  3. Pass HI. Contemporary approaches in the investigation and treatment of malignant pleural mesothelioma. Chest Surg Clin N Am 1994;4:497–515.[Medline]
  4. Rusch VW. Clinical features and current treatment of diffuse malignant pleural mesothelioma. Lung Cancer 1995;12:S127–46.
  5. Rusch VW. Trials in malignant mesothelioma. LCSG 851 and 882. Chest 1994;106:359S--62S.[Abstract/Free Full Text]
  6. Rusch VW. Mesothelioma and less common tumors. In: Pearson FG, Deslauriers J, Ginsberg RJ, Hiebert CA, McKneally MF, Urschel HC, eds. Thoracic surgery. New York: Churchill Livingstone, 1995:1083--105.
Articles of Historical Interest and Perspective

  1. Antman KH. Current concepts: malignant mesothelioma. N Engl J Med 1980;303:200–2.[Medline]
  2. Bamler KJ, Maassen W. The percentage of benign and malignant pleural tumors among the patients of a clinic of lung surgery with special consideration of the malignant pleural mesothelioma and its radical treatment, including results of diaphragm substitution with preserved dura mater. Thoraxchir Vask Chir 1974;22:386–91.[Medline]
  3. Hillerdal G. Malignant mesothelioma. 1982: Review of 4710 published cases. Br J Dis Chest 1983;77:321–43.[Medline]
  4. Klemperer P, Rabin CB. Primary neoplasms of the pleura. A report of five cases. Arch Pathol 1931;11:384–412.
  5. Martini N, McCormack PJ, Bains MS, et al. Pleural mesothelioma. Ann Thorac Surg 1987;43:113–20.[Abstract]
  6. McCormack PM, Nagasaki F, Hilaris BS, Martini N. Surgical treatment of pleural mesothelioma. J Thorac Cardiovasc Surg 1982;84:834–42.[Abstract]
  7. Okike N, Bernatz, P, Woolner LB. Localized mesothelioma of the pleura: benign and malignant variants. J Thorac Cardiovasc Surg 1978;75:363–72.[Abstract]
  8. Selikoff IJ, Churgh J, Hammond EC. Relation between exposure to asbestos and mesothelioma. N Engl J Med 1965;272:560–5.
  9. Vogelzang NJ, Schultz SM, Iannucci AM, et al. Malignant mesothelioma. The University of Minnesota experience. Cancer 1984;53:377–83.[Medline]
  10. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Industr Med 1960;17:260–71.[Medline]
  11. Wagner JC. Mesothelioma and mineral fibers. Cancer 1986;57:1905–11.[Medline]
  12. Whitwell PR, Rawcliffer RM. Diffuse malignant pleural mesothelioma and asbestos exposure. Thorax 1971;26:6–22.[Abstract/Free Full Text]
  13. Whitwell F, Scott J, Grimshaw M. Relationship between occupations and asbestos-fiber content of the lungs in patients with pleural mesothelioma, lung cancer, and other diseases. Thorax 1977;32:377–86.[Abstract/Free Full Text]
Histology, Classification, and Staging

  1. Johansson L, Linden CJ. Aspects of histopathologic subtype as a prognostic factor in 85 pleural mesotheliomas. Chest 1996;109:109–14.[Abstract/Free Full Text]
  2. McCaughey WTE. Asbestos and neoplasia: diffuse mesothelial tumors. Criteria for diagnosis of diffuse mesothelial tumors. Ann N Y Acad Sci 1965;132:603–13.[Medline]
  3. Rusch VW. A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. Chest 1995;108:1122–8.[Abstract/Free Full Text]
  4. Rusch VW, Venkatraman E. The importance of surgical staging in the treatment of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 1996;111:815–26.[Abstract/Free Full Text]
  5. Sugarbaker DJ, Strauss GM, Lynch TJ, et al. Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J Clin Oncol 1993;11:1172–8.[Abstract/Free Full Text]
Pleuropneumonectomy

  1. Allen KB, Faber LP, Warren WH. Malignant pleural mesothelioma. Extrapleural pneumonectomy and pleurectomy. Chest Surg Clin N Am 1994;4:113–26.[Medline]
  2. Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 1976;31:15–24.[Abstract/Free Full Text]
  3. DaValle MJ, Faber LP, Kittle CF, et al. Extrapleural pneumonectomy for diffuse, malignant mesothelioma. Ann Thorac Surg 1986;612--8.
  4. Faber LP. Extrapleural pneumonectomy for diffuse, malignant mesothelioma. Update. Ann Thorac Surg 1994;58:1782–3.[Medline]
  5. Harpole DH, Liptay MJ, DeCamp MM Jr, Mentzer SJ, Swanson SJ, Sugarbaker DJ. Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias. Ann Thorac Surg 1996;61:977–82.[Abstract/Free Full Text]
  6. Rusch VW, Piantadosi S, Holmes EC. The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial. J Thorac Cardiovasc Surg 1991;102:1–9.[Abstract]
Radiation Therapy

  1. Ball DL, Cruickshank DG. The treatment of malignant mesothelioma of the pleura: review of a 5-year experience, with special reference to radiotherapy. Am J Clin Oncol 1990;13:4–9.[Medline]
  2. Maasilta P. Deterioration in lung function following hemithorax irradiation for pleural mesothelioma. Int J Radiat Oncol Biol Phys 1991;20:433–8.[Medline]
Current Chemotherapy

  1. Hunt KJ, Longton G, Williams MA, Livingston RB. Treatment of malignant mesothelioma with methotrexate and vinblastine, with or without platinum chemotherapy. Chest 1996;109:1239–42.[Abstract/Free Full Text]
  2. Ong ST, Vogelzang NJ. Chemotherapy in malignant pleural mesothelioma. A review. J Clin Oncol 1996;14:1007–17.[Abstract/Free Full Text]
  3. Shin DM, Fossella FV, Umsawasdi T, et al. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma. Cancer 1995;76:2230–6.[Medline]
Multimodality Regimens

  1. Keller SM. Adjuvant therapy for malignant pleural mesothelioma. Chest Surg Clin N Am 1994;4:27–35.
  2. Lee JD, Perez S, Wang HJ, Figlin RA, Holmes EC. Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: the UCLA experience. J Surg Oncol 1995;60:262–7.[Medline]
  3. Rice TW, Adelstein DJ, Kirby TJ, et al. Aggressive multimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 1994;58:24–9.[Abstract]
  4. Rusch V, Saltz L, Venkatraman E, et al. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. J Clin Oncol 1994;12:1156–63.[Abstract/Free Full Text]
  5. Rusch VW. Pleurectomy and decortication and adjuvant therapy for malignant mesothelioma. Chest 1993;103:382AS.
  6. Sauter ER, Langer C, Coia LR, Goldberg M, Keller SM. Optimal management of malignant mesothelioma after subtotal pleurectomy: revisiting the role of intrapleural chemotherapy and postoperative radiation. J Surg Oncol 1995;60:100–5.[Medline]
  7. Sugarbaker DJ, Jaklitsch MT, Liptay MJ. Mesothelioma and radical multimodality therapy: who benefits? Chest 1995;107:345S--50S.[Abstract/Free Full Text]
  8. Sugarbaker DJ, Mentzer SJ, DeCamp M, et al. Extrapleural pneumonectomy in the setting of multimodality approach to malignant mesothelioma. Chest 1993;103:377S--81S.
Pleurodesis and Thoracoscopy

  1. Boutin C, Rey F. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis., Cancer 1993;72:389–93.[Medline]
  2. Boutin C, Rey F, Gouvernet J, Viallat JR, Astoul P, Ledoray V. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: Prognosis and staging. Cancer 1993;72:394–404.[Medline]
  3. Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest 1995;108:754–8.[Abstract/Free Full Text]
  4. Macha HN, Reichle G, von Zwehl D, Kemmer HP, Bas R, Morgan JA. The role of ultrasound assisted thoracoscopy in the diagnosis of pleural disease. Clinical experience in 687 cases. Eur J Cardiothorac Surg 1993;7:19–22.[Abstract]
Intrapleural Therapies (Photodynamic and Others)

  1. Astoul P, Viallat JR, Laurent JC, Brandely M, Boutin C. Intrapleural recombinant IL-2 in passive immunotherapy for malignant pleural effusion. Chest 1993;103:209–13.[Abstract/Free Full Text]
  2. Boutin C, Nussbaum E, Monnet I, et al. Intrapleural treatment with recombinant gamma-interferon in early stage malignant pleural mesothelioma. Cancer 1994;74:2460–7.[Medline]
  3. Luketich JD, Westkaemper J, Sommers KE, Ferson PF, Keenan RJ, Landreneau RJ. Bronchoesophagopleural fistula after photodynamic therapy for malignant mesothelioma. Ann Thorac Surg 1996;62:283–4.[Abstract/Free Full Text]
  4. Pass HI, DeLaney TF, Tochner Z, et al. Intrapleural photodynamic therapy: results of a phase I trial. Ann Surg Oncol 1994;1:28–37.[Medline]
  5. Pass HI, Donington JS. Use of photodynamic therapy for the management of pleural malignancies. Semin Surg Oncol 1995;11:360–7.[Medline]
  6. Pass HW, Temeck BK, Kranda K, Steinberg SM, Pass HI. A phase II trial investigating primary immunochemotherapy for malignant pleural mesothelioma and the feasibility of adjuvant immunochemotherapy after maximal cytoreduction. Ann Surg Oncol 1995;2:214–20.[Medline]
  7. Takita H, Dougherty TJ. Intracavitary photodynamic therapy for malignant pleural mesothelioma. Semin Surg Oncol 1995;11:368–71.[Medline]
  8. Takita H, Mang TS, Loewen GM, et al. Operation and intracavitary photodynamic therapy for malignant pleural mesothelioma: a phase II study. Ann Thorac Surg 1994;58:995–8.[Abstract]
Gene Therapy

  1. Hwang HC, Smythe WR, Elshami AA, et al. Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer. Am J Respir Cell Mol Biol 1995;13:7–16.[Abstract]
  2. Smythe WR, Hwang HC, Amin KM, et al. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system. Cancer Res 1994;54:2055–9.[Abstract/Free Full Text]
  3. Smythe WR, Hwang HC, Elshami AA, et al. Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene. Ann Surg 1995;222:78–86.[Medline]
Malignant Pleural Effusions: Diagnosis and Management

  1. Fenton KN, Richardson JD. Diagnosis and management of malignant pleural effusions. Am J Surg 1995;170:69–74.[Medline]
  2. Fry WA, Khandekar JD. Parietal pleurectomy for malignant pleural effusion. Ann Surg Oncol 1995;2:160–4.[Medline]
  3. Harvey JC, Erdman CB, Beattie EJ. Early experience with videothoracoscopic hydrodissection pleurectomy in the treatment of malignant pleural effusion. J Surg Oncol 1995;59:243–5.[Medline]
  4. Moores DW. Management of the malignant pleural effusion. Chest Surg Clin N Am 1994;4:481–95.[Medline]
  5. Ruckdeschel JC. Management of malignant pleural effusions. Semin Oncol 1995;22:58–63.
Web Resources and Links Information and Links for Physicians and Surgeons

  1. National Cancer Institute: PDQ Information for Health Care Professionals, redistributed by University of Bonn, Medical Center (http://www.meb.uni-bonn.de/cancernet/101071.html).
  2. National Cancer Institute CancerNet: "Malignant mesothelioma" (http://www.arc.com/database/Cancernet/Cancerlit/Thoracic_Cancers/).
  3. National Cancer Institute: PDQ Clinical trials pertaining to malignant mesothelioma. (http://wwwicic.nci.nih.gov/prot/menu/dx01071.html).
  4. The University of Pennsylvania Oncolink: ``Mesothelioma'' (http://cancer.med.upenn.edu/disease/mesothelioma/).
  5. University of Pennsylvania Medical Center, Center for Lung Cancer and Related Disorders: Clinical trials: Mesothelioma (http://www.centerwatch.com/CAT192.HTM).
  6. US Department of Labor, Occupational Safety & Health Administration. Standards relating to asbestos (http://www.osha-slc.gov/OshStd_data/1910.1001.html).
Patient Case and Pathology Presentations

  1. PATH Gallery: Department of Pathology, University of Udine, Italy (http://www.uniud.it/drmm/anpat/gallery/casi/c3eng.html).
  2. UAB radiology teaching file: Chest case 1 (malignant mesothelioma) (http://www.rad.uab.edu/UAB_Radiology_Teach_File/chest/chest_case1/chest_case1a.html).
  3. UNC Radiology teaching file chest section case #1 (malignant mesothelioma) (http://sunsite.unc.edu/jksmith/UNC-Radiology-Webserver/Chest/C1.html).
Federal Case Accounts and Awards Related to Asbestos

  1. Summary Judgment account of Docket No. 90--3869 In the United States Court of Appeals for the Seventh Circuit (http://www.kentlaw.edu/7circuit/1995/oct/90--3869.htm).
  2. The Villanova Center for Information Law and Policy: United States Court of Appeals for the Third Circuit nos. 94--1745 and 94--1746 (http://www.law.vill.edu/Fed-Ct/Circuit/3d/opinins/95a1018p.htm).
Asbestos Information From the Canadian Asbestos Institute

  1. http://www.asbestos-institute.ca/specialreports/specialindex.html
  2. http://www.asbestos-institute.ca/specialreports/meso.html




This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Campbell, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campbell, D. B.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS